Mitophagy in Botulinum Toxin Type A ‐Induced Muscle Atrophy
Oral Diseases · 2026-05 · 32 (5) · 1471-1479
DOI: 10.1111/odi.70168 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, online erschienen am 12.12.2025. Verfasst von Qian-Ying Mao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clini…. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Masseter Muscle, Mitophagy, Muscular Atrophy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
Botulinum toxin type A (BTXA) is widely used in oral and maxillofacial surgery to treat masseter hypertrophy and bruxism, inducing transient masseter atrophy, but the underlying mechanisms remain unclear. Mitophagy, essential for muscle fiber homeostasis, plays a critical role in muscle atrophy. This study aims to investigate whether mitophagy mediates BTXA‐induced masseter muscle atrophy.
Methods
Rats received BTXA injections into masseter for 2 and 8 weeks. Muscle fiber composition was assessed via histology and immunofluorescence. Mitophagy markers (LC3‐II, p62, beclin‐1, Tomm20) were quantified by western blot. Mitochondrial function was evaluated via ATP content and mitochondrial DNA (mtDNA) copy number.
Results
BTXA injection led to transient masseter muscle atrophy. During this process, the proportion of type IIA muscle fibers significantly increased, while the proportion of type IIB fibers decreased. Additionally, at 2 weeks post‐BTXA injection, the expression levels of LC3‐II, p62, and beclin‐1 were notably upregulated, whereas Tomm20 expression was downregulated. Furthermore, a significant reduction in ATP content and mtDNA copy number was observed at the same time point, indicating impaired mitochondrial function.
Conclusion
These findings suggest that mitophagy plays a crucial role in BTXA‐induced masseter muscle atrophy, providing new insights into the mechanisms underlying BTXA treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research…
- Department of Physiology and Pathophysiology, Peking University School of Basic Medical Sciences, Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education, Beijing, China.
ORCID-Profile: Ruo-Lan Xiang, Zhi-Gang Cai
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Mao, Q. Y., Chen, Z., Xie, S., Xiang, R. L., & Cai, Z. G. (2026). Mitophagy in Botulinum Toxin Type A ‐Induced Muscle Atrophy. Oral Diseases, 32(5), 1471-1479. https://doi.org/10.1111/odi.70168
Vancouver
Mao QY, Chen Z, Xie S, Xiang RL, Cai ZG. Mitophagy in Botulinum Toxin Type A ‐Induced Muscle Atrophy. Oral Diseases. 2026;32(5):1471-1479. doi:10.1111/odi.70168
BibTeX
@article{Mao2026,
author = {Mao, Qian-Ying and Chen, Zhuo and Xie, Shang and Xiang, Ruo-Lan and Cai, Zhi-Gang},
title = {Mitophagy in Botulinum Toxin Type A ‐Induced Muscle Atrophy},
journal = {Oral Diseases},
year = {2026},
volume = {32},
number = {5},
pages = {1471--1479},
doi = {10.1111/odi.70168}
}
EUVIMED